Insulin Resistance and Pharmacotherapy Effectiveness in Patients with Long - Term Diabetes Mellitus Type 2

Yulia Andreevna Sorokina; Lovcova Lubov Valerievna; Zanozina Olga Vladimirovna; Urakov Alexander Livevich

Authors

Yulia Andreevna Sorokina
Lovcova Lubov Valerievna
Zanozina Olga Vladimirovna
Urakov Alexander Livevich

Keywords:

type 2 diabetes mellitus, monotherapy, methformin, eNOS3 gene polymorphism, insulin resistance.

Abstract

Abstract not found

Downloads

Article PDF

How to Cite

Insulin Resistance and Pharmacotherapy Effectiveness in Patients with Long - Term Diabetes Mellitus Type 2. (2020). Global Journal of Medical Research, 20(B8), 15-20. https://medicalresearchjournal.org/index.php/GJMR/article/view/102797

Download Citation

References

(2017) International Diabetes Federation (IDF).

Andrew Hattersley, Kashyap Patel (2017) Precision diabetes: learning from monogenic diabetes. 60(5), 769-777.

Sorokina Yu, L Lovtsova, A Urakov, O Zanozina (2019) Genetic Polymorphism in Patients with Newly Diagnosed Type 2 Diabetes Mellitus. 11(2), 57-62.

D Rotroff (2018) Genetic Variants in CPA6 and PRPF31 Are Associated With Variation in Response to Metformin in Individuals With Type 2. 67, 1428-1440.

Ivan Dedov, Marina Kalashnikova, Dmitriy Belousov, Vladimir Rafalskiy, Victor Kalashnikov, Aleksey Kolbin, Diana Yazykova, Leonid Ivanenko (2016) Assessing routine healthcare pattern for type 2 diabetes mellitus in Russia: the results of рharmacoepidemiological study (FORSIGHT-DM2). 19(6), 443-456.

Ivan Dedov, Marina Kalashnikova, Dmitriy Belousov, Aleksey Kolbin, Vladimir Rafalskiy, Aleksey Cheberda, Mariya Kantemirova, Vadim Zakiev, Valentin Fadeyev (2017) Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM). 20(6), 403-419.

M Shestakova (2019) Algorithms of specialized medical care for diabetes mellitus patients, 8th Edition: what innovations?. 19(4), 20-22.

Ivan Kuznetsov, V Serezhenkov, Tatiana Romantsova, A Vanin (2013) Metformin regulates glycemic homeostasis in patients with type 2 diabetes mellitus as an NO donor. 16(3), 116-116.

Rafael Alvim, Marcel Cheuhen, Silmara Machado, André Sousa, Paulo Santos (2015) General aspects of muscle glucose uptake. 87(1), 351-368.

Michael Madison (2017) Beyond Invention: Patent as Knowledge Law. 2626670(2).

Sorokina Yu, O Zanozina, L Lovcova, M Seropyan, Yu Method for predicting the effectiveness of treatment of patients with type 2 diabetes.

I Dedov, M Shestakova, A Majorov, Yu (2019) Algorithms for specialized medical care for patients with diabetes. 212.

Isabel Huguet, Georgia Ntali, Ashley Grossman, Niki Karavitaki (2015) Cushing's Disease - Quality of Life, Recurrence and Long-term Morbidity. 11(1), 34.

A Ametov, M Prudnikova (2015) Sustained release metformin is a new standard in the treatment of type 2 diabetes. 1, 19-26.

O Zanozina, Yu. Sorokina, L Lovtsova, A Urakov (2018) Gliptins in the Incretin-Based Pharmacotherapy of Diabetes Mellitus: Opportunities and Personalization. 112.